Investors & Media

Press Release

Printer Friendly Version View printer-friendly version
<< Back
Flex Pharma Presenting at Upcoming Investor Conferences in June 2016

BOSTON--(BUSINESS WIRE)--Jun. 3, 2016-- Click to Tweet

Flex Pharma, Inc. (NASDAQ: FLKS) today announced that it will present a corporate overview at the following upcoming investor conferences in June:

  • The Jefferies 2016 Healthcare Conference on June 9, 2016 at 11:30 a.m. in New York, NY;
  • The 36th Annual Piper Jaffray Consumer Conference on June 15, 2016 at 10:50 a.m. in New York, NY;
  • The JMP Securities 2016 Life Sciences Conference on June 21, 2016 at 9:00 a.m. in New York, NY; and
  • The 3rd Annual ROTH Healthcare Day on June 22, 2016 in London, UK.

A live webcast of Flex Pharma’s presentations at these conferences may be accessed in the Investor section of the Company’s website at Please log on to the Flex Pharma website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Flex Pharma’s website for 2 weeks following each presentation.

About Flex Pharma

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps, cramps and spasms associated with severe neuromuscular conditions such as MS and ALS, and exercise-associated muscle cramps. Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.

Visit for updates and to learn more about HOTSHOT, the Company’s consumer product which is scientifically proven to prevent and treat muscle cramps.

HOTSHOT is a consumer product that is marketed to endurance athletes. HOTSHOT complements the Company’s drug development business and is not intended to diagnose, treat, cure or prevent any disease.

Follow Flex Pharma (@flexpharma) and HOTSHOTTM (@Team_HOTSHOT) on Twitter

Source: Flex Pharma, Inc.

Flex Pharma, Inc.
Elizabeth Woo, 617-874-1829
SVP, Investor Relations & Corporate Communications